Stemline Therapeutics, Inc.
1675 York Avenue
Suite 30-E
New York
New York
10128
United States
Tel: 212-831-1111
Website: http://www.stemline.com/
Email: info@stemline.com
139 articles about Stemline Therapeutics, Inc.
-
Stemline Therapeutics, Inc. To Present At The Wedbush Life Sciences Management Access Conference
8/5/2014
-
Stemline Therapeutics, Inc. Announces Opening Of SL-401 Corporate IND And Start Of Clinical Trials In BPDCN And AML
7/28/2014
-
Stemline Therapeutics, Inc. To Present At The 2014 Wells Fargo Securities Healthcare Conference
6/10/2014
-
Stemline Therapeutics, Inc. To Present At The Jefferies and Co. 2014 Global Healthcare Conference
5/28/2014
-
Stemline Therapeutics, Inc. Announces Presentation Of SL-401 Preclinical Efficacy Data In Multiple Myeloma At The 2014 American Society of Clinical Oncology Annual Meeting
5/19/2014
-
Stemline Therapeutics, Inc. To Present At The Deutsche Bank 39th Annual Health Care Conference
4/30/2014
-
Stemline Therapeutics, Inc. Announces FDA Acceptance Of IND For SL-701, A Synthetic Multi-Peptide Vaccine Targeting Glioma Brain Tumors
4/8/2014
-
Stemline Therapeutics, Inc. To Present At The 13th Annual Needham Healthcare Conference
4/7/2014
-
Stemline Therapeutics, Inc. Announces Presentation Of SL-501 Preclinical Efficacy Data In TKI-Resistant CML At The Annual Meeting Of The American Association for Cancer Research
4/1/2014
-
Stemline Therapeutics, Inc. To Present At The 26th Annual ROTH Conference
3/6/2014
-
Stemline Therapeutics, Inc. To Present At Cowen And Company Health Care Conference
2/26/2014
-
Stemline Therapeutics, Inc. To Present At Citi 2014 Global Healthcare And RBC Capital Markets Conferences
2/20/2014
-
Stemline Therapeutics, Inc. To Present At The Leerink Swann and Company Global Healthcare Conference
2/6/2014
-
Stemline Therapeutics, Inc. To Present At The 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/4/2014
-
Stemline Therapeutics, Inc. To Present At The 32nd Annual J.P. Morgan Healthcare Conference
1/7/2014
-
Stemline Therapeutics, Inc. To Present At The Oppenheimer 24th Annual Healthcare Conference
12/5/2013
-
Stemline Therapeutics, Inc. Announces The Presentation Of Clinical Trial Results With A Synthetic Peptide Vaccine For Brain Cancer, Now Being Developed As SL-701, At The Society Of Neuro-Oncology (SNO) Annual Meeting
11/25/2013
-
Stemline Therapeutics, Inc. Announces Clinical Trial Results With SL-701, A Phase 2 Therapeutic for High-Grade Glioma, In An Additional Indication: Data To Be Presented At The Society of Neuro-Oncology (SNO) Annual Meeting
11/19/2013
-
Stemline Therapeutics, Inc. Announces Five Presentations At The American Society of Hematology Annual Meeting, Including A Clinical Update Of SL-401 In BPDCN
11/14/2013
-
Stemline Therapeutics, Inc. and The Leukemia & Lymphoma Society Announce Collaboration to Accelerate the Development of SL-401 in Hematologic Cancers and Increase Awareness of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
10/29/2013